We are live on ! Find out more
Aspiriant LLC

Aspiriant LLC Portfolio holdings

AUM $4.08B Turnover 21.3%
1-Year Est. Return 12.02%
 

Aspiriant is an employee-owned wealth management firm with accounting roots that pairs financial planning with tax-conscious investing. Formed in 2008 and briefly named Kochis Fitz/Quintile that year, it has since brought together several firms whose client relationships go back many years, in some cases decades. Its investment approach is globally diversified and value-oriented. The firm advises the Aspiriant Affiliated Mutual Funds, which give clients access to private investments. Its clients are mainly high net worth individuals and families, along with professional fiduciaries.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+12.02%
3 Year Est. Return
+52.7%
5 Year Est. Return
+47.97%
10 Year Est. Return
+142.06%
AUM
$4.08B
AUM Growth
+$32.7M
Cap. Flow
+$42.9M
Cap. Flow %
1.05%
Top 10 Hldgs %
64.79%
Holding
460
New
60
Increased
185
Reduced
136
Closed
38
Avg Time Held
4.2 years
Top 10 Avg Time Held
6 years
Top 20 Avg Time Held
6.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.16%
2 Technology 4.02%
3 Financials 1.91%
4 Communication Services 1.2%
5 Healthcare 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PEP icon
101
PepsiCo
PEP
$192B
$2.34M 0.06%
18,491
+383
+2% +$52.8K
2016 Q1
42 quarters
BAC icon
102
Bank of America
BAC
$325B
$2.32M 0.06%
42,600
+6,202
+17% +$378K
2018 Q1
34 quarters
SCHW icon
103
Charles Schwab
SCHW
$156B
$2.31M 0.06%
23,634
-213
-0.9% -$22.4K
2016 Q1
42 quarters
CSCO icon
104
Cisco
CSCO
$357B
$2.31M 0.06%
21,438
-345
-2% -$38.9K
2018 Q1
34 quarters
V icon
105
Visa
V
$750B
$2.26M 0.06%
6,277
+535
+9% +$196K
2018 Q1
34 quarters
LLY icon
106
Eli Lilly
LLY
$1.2T
$2.25M 0.06%
1,943
+30
+2% +$35.4K
2022 Q4
15 quarters
SDY icon
107
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$2.21M 0.05%
15,106
+1
+0% +$155
2018 Q1
34 quarters
BILL icon
108
BILL Holdings
BILL
$5.28B
$2.21M 0.05%
51,841
-2,550
-5% -$118K
2020 Q2
25 quarters
AMGN icon
109
Amgen
AMGN
$236B
$2.2M 0.05%
5,217
+1,208
+30% +$481K
2013 Q3
52 quarters
TDG icon
110
TransDigm Group
TDG
$61.2B
$2.17M 0.05%
2,000
-2
-0.1% -$2.4K
2024 Q3
8 quarters
ESML icon
111
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.55B
$2.12M 0.05%
40,817
+474
+1% +$25.8K
2025 Q4
3 quarters
COST icon
112
Costco
COST
$488B
$2.11M 0.05%
2,319
-38
-2% -$35.5K
2018 Q1
34 quarters
SCHB icon
113
Schwab US Broad Market ETF
SCHB
$40.6B
$2.1M 0.05%
71,710
-8,863
-11% -$260K
2021 Q4
19 quarters
ABBV icon
114
AbbVie
ABBV
$506B
$2.1M 0.05%
8,016
-2,537
-24% -$650K
2018 Q1
34 quarters
TSLA icon
115
Tesla
TSLA
$1.37T
$2.08M 0.05%
5,863
+8
+0.1% +$2.86K
2020 Q3
24 quarters
VYM icon
116
Vanguard High Dividend Yield ETF
VYM
$78.3B
$2.04M 0.05%
13,145
+858
+7% +$139K
2021 Q1
22 quarters
MDY icon
117
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$23.9B
$1.99M 0.05%
3,036
-27
-0.9% -$18.6K
2018 Q1
34 quarters
MRK icon
118
Merck
MRK
$330B
$1.98M 0.05%
13,635
-3,924
-22% -$542K
2018 Q1
34 quarters
EAGL icon
119
Eagle Capital Select Equity ETF
EAGL
$4.59B
$1.98M 0.05%
58,062
– –
2026 Q2
1 quarter
EAGG icon
120
iShares ESG Aware US Aggregate Bond ETF
EAGG
$5.1B
$1.96M 0.05%
43,218
– –
2023 Q4
11 quarters
SHV icon
121
iShares 0-1 Year Treasury Bond ETF
SHV
$21.4B
$1.92M 0.05%
17,429
– –
2019 Q1
30 quarters
DFAI icon
122
Dimensional International Core Equity Market ETF
DFAI
$16.9B
$1.91M 0.05%
+46,041
New +$1.95M
2026 Q3
0 quarters
INTC icon
123
Intel
INTC
$273B
$1.86M 0.05%
15,474
+1,732
+13% +$177K
2018 Q1
34 quarters
UNP icon
124
Union Pacific
UNP
$171B
$1.84M 0.05%
6,752
+141
+2% +$41K
2016 Q1
42 quarters
ABT icon
125
Abbott
ABT
$178B
$1.82M 0.04%
18,416
-96
-0.5% -$10K
2016 Q1
42 quarters

Similar funds

Aspiriant LLC's Q3 2026 Portfolio in Review

As of Q3 2026, Aspiriant LLC held 460 positions worth $4.08B, up 0.81% from $4.05B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Aspiriant LLC's Q3 2026 filing shows 60 new, 185 increased, 136 reduced and 38 closed positions. Its largest new stake was iShares California Muni Bond ETF: 47,237 shares worth $2.56M. The largest sale was Dimensional US Core Equity 2 ETF, an estimated $14.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Financials.

  • Aspiriant LLC's largest Q3 2026 buy was iShares California Muni Bond ETF: 47,237 shares worth $2.56M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q3 2026, an estimated $19.6M increase.
  • Aspiriant LLC's biggest Q3 2026 reduction was Vanguard S&P Small-Cap 600 Value ETF, cutting an estimated $2.25M.
  • Aspiriant LLC fully exited Dimensional US Core Equity 2 ETF in Q3 2026, selling an estimated $14.2M.
  • Aspiriant LLC's ten largest holdings make up 65% of its $4.08B portfolio in Q3 2026.
  • Aspiriant LLC opened 60 new positions and closed 38 in Q3 2026.
  • Aspiriant LLC's portfolio value rose 0.81% quarter-over-quarter to $4.08B.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.